Search

everythinglearnresearchcommunity

for

Search:↓

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

Sodium valproate can worsen psoriasis-like skin conditions.

Sodium valproate reduced seizures in many patients with resistant epilepsy.

Sodium valproate is not recommended as a first-line treatment for neuropathy but may be used in resistant cases.

Sodium valproate effectively reduces seizures in epilepsy, especially in absences and myoclonic types, with minimal side effects.

Sodium valproate can cause severe liver disease and side effects, sometimes leading to death.

Higher doses of the medication valproate can cause hair loss, which may stop when the dose is lowered or the medication is stopped.

Sodium valproate improved epilepsy control in most children but often caused weight gain and other mild side effects.

Sodium valproate effectively controls petit mal seizures in children but is less effective for other types, with minimal side effects.

Sodium valproate can cause low platelets and hair loss.

Long-term sodium valproate treatment for epilepsy generally caused mild and temporary side effects.

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.

Dihydroxyacetone in self-tanning lotion helped reduce sun-related skin issues in a woman with variegate porphyria.

Levetiracetam and valproate sodium both reduce seizures when added to lamotrigine, but levetiracetam has fewer side effects.

Progesterone protects brain cells, but Provera does not.

Agomelatine might help reduce hair loss caused by valproate.

Agomelatine might help stop hair loss caused by valproate.

Sodium valproate improved epilepsy control but often caused weight gain in children.

Both topiramate and divalproex sodium effectively reduce migraine frequency and are generally well-tolerated.

Sodium valproate can cause low platelet count.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Metal binding to sodium valproate may be linked to hair loss in epilepsy patients.

Sodium valproate caused hair loss and curly hair in 3.5% of patients.

Avacopan may cause unexpected side effects, so early monitoring is important.

Retinol acetate can reduce the harmful effects of the drug benoxaprofen on white blood cells.

Liver transplantation is a viable option for children with propionic acidemia, improving quality of life and diet, but does not remove all risks and long-term brain outcomes are uncertain.

Acetylsalicylic acid affects platelet-rich plasma activation, requiring personalized approaches for effective treatment.